Loading
Amarin CORP Plc\uk Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Berg Aaron, was filed 05 Aug 2024.
Insider Decl.
1,020
Thresholds
n/a
Buy Volume
€737,111
17 ops. · all time
Sell Volume
€146M
123 ops. · all time
Since the insiders bought
- +6.0%Entry US$14.20 · Close at T+365 US$15.05
- -50.0%Entry US$25.20 · Close at T+365 US$12.60
- -30.0%Entry US$34.00 · Close at T+365 US$23.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,567 of 26,246 companies
34.7
score / 100
Value33
Quality36
FCF yld2.8%
Earn yld-16%
EV/EBITDA·
ROE-6.0%
Gross mgn57%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$11.51
Analyst consensus
2 analysts4.50/5
US$12.00Target US$12.50(+9%)US$13.00
Income statement
RevenueUS$213.6M
Gross profitUS$120.9M57% margin
EBITDA-US$33M-15% margin
Net income-US$38.8M-14.6% margin
Valuation
PER (forward)16.1x
P/Book0.5x
Beta0.77
Balance sheet & cash
Market capUS$241.4M
Total debtUS$6.1M
Free Cash FlowUS$6.7M
Debt / Equity2%
Profitability & ownership
ROE-6.0%
ROA-2.3%
% insiders37.2%
% institutions20.8%
Last declaration on 3 August 2026
Declarations1,020 total
313 sharesAmerican Depositary ShareSEC:0001193125-26-330669:0
155 shares@ US$14.260.0008% mcap3.6% of flowAmerican Depositary ShareSEC:0001193125-26-330669:1
3,688 sharesAmerican Depositary SharesSEC:0001193125-26-304910:0
3,688 sharesAmerican Depositary SharesSEC:0001193125-26-304911:0
3,688 sharesAmerican Depositary SharesSEC:0001193125-26-304912:0
2,447 sharesAmerican Depositary SharesSEC:0001193125-26-304914:0
1,264 shares@ US$15.940.0072% mcap50.0% of flowAmerican Depositary SharesSEC:0001193125-26-304910:1
1,887 shares@ US$15.940.011% mcap19.7% of flowAmerican Depositary SharesSEC:0001193125-26-304911:1
1,926 shares@ US$15.940.011% mcap34.6% of flowAmerican Depositary SharesSEC:0001193125-26-304912:1
1,206 shares@ US$15.940.0068% mcap32.1% of flowAmerican Depositary SharesSEC:0001193125-26-304914:1
6,250 sharesAmerican Depositary SharesSEC:0001193125-26-290834:0
3,197 sharesAmerican Depositary SharesSEC:0001193125-26-290834:1
403 shares@ US$14.980.0018% mcap59.5% of flowAmerican Depositary SharesSEC:0001193125-26-170731:1
838 sharesAmerican Depositary SharesSEC:0001193125-26-170731:0
438 shares@ US$14.980.0018% mcap61.5% of flowAmerican Depositary SharesSEC:0001193125-26-167112:1
403 shares@ US$14.980.0017% mcap59.5% of flowAmerican Depositary SharesSEC:0001193125-26-167113:1
403 shares@ US$14.980.0017% mcap59.5% of flowAmerican Depositary SharesSEC:0001193125-26-167114:1
403 shares@ US$14.980.0017% mcap59.5% of flowAmerican Depositary SharesSEC:0001193125-26-167117:1
403 shares@ US$14.980.0017% mcap59.5% of flowAmerican Depositary SharesSEC:0001193125-26-167118:1
403 shares@ US$14.980.0017% mcap59.5% of flowAmerican Depositary SharesSEC:0001193125-26-167119:1
838 sharesAmerican Depositary SharesSEC:0001193125-26-167112:0
838 sharesAmerican Depositary SharesSEC:0001193125-26-167113:0
838 sharesAmerican Depositary SharesSEC:0001193125-26-167114:0
838 sharesAmerican Depositary SharesSEC:0001193125-26-167117:0
838 sharesAmerican Depositary SharesSEC:0001193125-26-167118:0
25 of 1020 declarations
About Amarin CORP Plc\uk
At Amarin, 611 option exercises and 269 grants dominate the 1,020 filings; the market trades are 123 sales worth EUR 146.5 million (median EUR 537,716) and 17 purchases worth EUR 737,111 (median EUR 28,966), so 12% are purchases. Joseph T. Kennedy (General Counsel) sold EUR 9,445,696 on January 24, 2019 and EUR 7,731,585 on September 24, 2018; John F. Thero (President and CEO) sold EUR 6,710,287 on November 11, 2019.
Purchases are modest: Patrick Holt (President and CEO) for EUR 135,701 on August 16, 2023, David M. Stack (Director) for EUR 101,506 on November 30, 2020 and Aaron Berg (President and CEO) for EUR 94,924 on August 2, 2024. The 17 purchases tracked to day 90 have a stored median of -27.9%, positive in 29% of cases (past results as stored, not a forecast).
Read moreShow less
Steven B. Ketchum (EVP, Chief Scientific Officer) is the top filer, with 229 filings, 31 of them sales; Joseph T. Kennedy signs 218, John F. Thero 142, Aaron Berg 137 and Michael Wayne Kalb (SVP and CFO) 115. Annual volume peaked at 220 in 2021 before dropping to 31 in 2022. 27 filers, 37.2% of the capital held by insiders. The last twelve months hold 52 filings, with no purchase or sale. Health care and pharma, USD 241.8 million.
